This mechanism could be linked to PPARγ down modulation reported after EVOO treatment because CD36 is a target gene of PPARγ; moreover, the latter is important in obesity pathogenesis also due to its involvement in lipid metabolism (31). This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.